AI-Driven Breast Cancer Treatment

Researchers have developed a spatially interpretable AI framework to tailor neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

One continuously updated timeline instead of dozens of separate articles. New developments are appended as the story evolves.

1. AnnouncementJun 18, 2026, 11:31 PM 74%

   Researchers develop AI framework for tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

   Researchers have developed a spatially interpretable AI framework to tailor neoadjuvant dual HER2 blockade in HER2-positive breast cancer.

   Read the full story →